Association of Hemometabolic Trajectory and Mortality: Insights From the Cardiogenic Shock Working Group Registry.


Journal

Journal of cardiac failure
ISSN: 1532-8414
Titre abrégé: J Card Fail
Pays: United States
ID NLM: 9442138

Informations de publication

Date de publication:
Oct 2024
Historique:
received: 31 01 2024
revised: 21 06 2024
accepted: 27 06 2024
medline: 11 10 2024
pubmed: 11 10 2024
entrez: 10 10 2024
Statut: ppublish

Résumé

Cardiogenic shock (CS) is a hemodynamic syndrome that can progress to systemic metabolic derangements and end-organ dysfunction. Prior studies have reported hemodynamic parameters at the time of admission to be associated with mortality but hemodynamic trajectories in CS have not been well described. We studied the association between hemodynamic profiles and their trajectories and in-hospital mortality in patients with CS due to heart failure (HF-CS) and acute myocardial infarction (MI-CS). Using data from the large multicenter Cardiogenic Shock Working Group (CSWG) registry, we analyzed hemodynamic data obtained at the time of pulmonary artery catheter (PAC) insertion (dataset at baseline) and at PAC removal or death (dataset at final time point). Univariable regression analyses for prediction of in-hospital mortality were conducted for baseline and final hemodynamic values, as well as the interval change (delta-P). Data was further analyzed based on CS etiology and survival status. A total of 2260 patients with PAC data were included (70% male, age 61 ± 14 years, 61% HF-CS, 27% MI-CS). In-hospital mortality was higher in the MI-CS group (40.1%) compared with HF-CS (22.4%, P < .01). In the HF-CS cohort, survivors exhibited lower right atrial pressure (RAP), pulmonary artery pressure (PAP), cardiac output/index (CO/CI), lactate, and higher blood pressure (BP) than nonsurvivors at baseline. In this cohort, during hospitalization, improvement in metabolic (aspartate transaminase, lactate), BP, hemodynamic (RAP, pulmonary artery pulsatility index [PAPi], pulmonary artery compliance for right-sided profile and CO/CI for left-sided profile), had association with survival. In the MI-CS cohort, a lower systolic BP and higher PAP at baseline were associated with odds of death. Improvement in metabolic (lactate), BP, hemodynamic (RAP, PAPi for right-sided profile and CO/CI for left-sided profile) were associated with survival. In a large contemporary CS registry, hemodynamic trajectories had a strong association with short-term outcomes in both cohorts. These findings suggest the clinical importance of timing and monitoring hemodynamic trajectories to tailor management in patients with CS.

Identifiants

pubmed: 39389726
pii: S1071-9164(24)00266-5
doi: 10.1016/j.cardfail.2024.06.019
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1196-1207

Informations de copyright

Copyright © 2024 Elsevier Inc. All rights reserved.

Auteurs

Wissam Khalife (W)

University of Texas Medical Branch, Galveston, Texas.

Manreet K Kanwar (MK)

Cardiovascular Institute at Allegheny Health Network, Pittsburgh, Pennsylvania.

Jacob Abraham (J)

Center for Cardiovascular Analytics, Providence Heart Institute, Portland, Oregon.

Song Li (S)

Medical City Healthcare, Dallas, Texas.

Kevin John (K)

The Cardiovascular Center, Tufts Medical Center, Boston, Massachusetts.

Shashank S Sinha (SS)

Inova Schar Heart and Vascular Institute, Inova Fairfax Medical Campus, Falls Church, Virginia.

Elric Zweck (E)

Heinrich Heine University, Dusseldorf, Germany.

Borui Li (B)

The Cardiovascular Center, Tufts Medical Center, Boston, Massachusetts.

Arthur R Garan (AR)

Beth Israel Deaconess Medical Center, Boston, Massachusetts.

Jaime Hernandez-Montfort (J)

Baylor Scott & White Health, Advanced Heart Failure Program Clinic, Temple, Texas.

Yijing Zhang (Y)

The Cardiovascular Center, Tufts Medical Center, Boston, Massachusetts.

VAN-Khue Ton (VK)

Massachusetts General Hospital, Boston, Massachusetts.

Maya Guglin (M)

Health Advanced Heart and Lung Care, Indianapolis, Indiana.

Rachna Kataria (R)

Brown University, Lifespan Cardiovascular Center, Providence, Rhode Island.

Gavin W Hickey (GW)

University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.

Saraschandra Vallabhajosyula (S)

Health Advanced Heart and Lung Care, Indianapolis, Indiana.

Chloe Kong (C)

Medical City Healthcare, Dallas, Texas.

Maryjane Farr (M)

UT Southwestern, Dallas, Texas.

Justin Fried (J)

Columbia University Irving Medical Center, New York New York.

Shelley Hall (S)

Baylor Scott & White Advanced Heart Failure Clinic, Dallas, Texas.

Neil M Harwani (NM)

The Cardiovascular Center, Tufts Medical Center, Boston, Massachusetts.

Claudius Mahr (C)

Medical City Healthcare, Dallas, Texas.

Sandeep Nathan (S)

University of Chicago, Chicago, Illinois.

Paavni Sangal (P)

The Cardiovascular Center, Tufts Medical Center, Boston, Massachusetts.

Andrew Schwartzman (A)

Maine Medical Center, Portland, Maine.

Arvind Bhimaraj (A)

Houston Methodist Research Institute, Houston, Texas.

J U Kim (JU)

Houston Methodist Research Institute, Houston, Texas.

Alec A Vishnevsky (AA)

Thomas Jefferson University Hospital, Philadelphia, Pennsylvania.

Esther Vorovich (E)

Northwestern Medicine, Chicago, Illinois.

Karol D Walec (KD)

The Cardiovascular Center, Tufts Medical Center, Boston, Massachusetts.

Peter Zazzali (P)

The Cardiovascular Center, Tufts Medical Center, Boston, Massachusetts.

Aiham Albaeni (A)

University of Texas Medical Branch, Galveston, Texas.

Daniel Burkhoff (D)

Cardiovascular Research Foundation, New York, New York.

Navin K Kapur (NK)

The Cardiovascular Center, Tufts Medical Center, Boston, Massachusetts. Electronic address: nkapur@tuftsmedicalcenter.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH